CNW/ - Hoffmann-La Roche Limited (Roche Canada) is pleased to announce, with support from the Government of Ontario through ...

Wish4Life Foundation, a US-based non-government organisation (NGO) dedicated to the care of children battling with cancer, is ...

In September 2024, UCB and Biogen reported successful results from their Phase III clinical trial of the PHOENYCS GO study, which tested dapirolizumab pegol as a treatment for moderate-to-severe ...

Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again ...

Cancer Immunotherapy market Latest Trend and Business Attractiveness 2024 to 2032 ...

However, in a newly published decision from an EPO board of appeal, T 56/21, the applicant (F. Hoffmann-La Roche AG) ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An ...

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

The Delhi High Court recently restored a single-judge order restraining Indian Pharma company Zydus Lifesciences ...

In July, a single-judge bench of the Delhi High Court restrained Zydus Lifesciences from selling its breast cancer drug in ...

Zydus had approached the Supreme Court challenging the Delhi High Court's order, which prevented the company from producing ...